RxDoctor Payments Data

Maziyar Daneshvar

White Plains, NYNPI 1356903124

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.3%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Medtronic at 35.8% of the total. Reporting peaked in 2023 at $4,884 and has fallen 57.6% since, to $2,072 in 2025.

$9,058in general payments, 2019–2025

Across 135 payments — averaging $67.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Abbott$2K
  • Atricure, Inc.$1K
  • Boston Scientific$670
  • Amgen$514
  • Merck$231
  • plus $1K from 20 others

What the payments were for

  • Consulting fees$1101%
  • Grants$2,00022%
  • Travel & lodging$2,02922%
  • Food & beverage$4,91954%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →